Effects of enteral nutrition enriched with omega-3 fatty acids on outcome in non-small cell lung cancer patients
Completed
- Conditions
- CancerNon Small Cell Lung Cancer (NSCLC)on-small cell lung cancer (NSCLC)
- Registration Number
- ISRCTN80845477
- Lead Sponsor
- Vrije University Medical Centre (VUMC) (Netherlands)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
1. Aged 18 to 75 years
2. Diagnosis NSCLC stage III
3. Resolved treatment plan: neo-adjuvant chemo(radiation)therapy during 6 weeks and, dependent on disease regression, tumour resection
4. Life expectancy greater than 3 months
5. Written informed consent
Exclusion Criteria
1. Surgery, chemo- or radiation therapy during the previous month
2. Oedema or ascites
3. Use of fish oil supplements during the last month
4. Use of high dose corticosteroids (low dose, inhalation steroids and/or local use is permitted)
5. Other active medical conditions (major gastrointestinal disease, chronic renal failure, uncontrolled diabetes mellitus, human immunodeficiency virus [HIV])
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Muscle strength<br>2. Immune status<br>3. Nutritional status<br>4. Cancer cachexia
- Secondary Outcome Measures
Name Time Method 1. Quality of life (QOL)<br>2. Physical activity level (PAL)<br>3. Post-operative complications and survival